Latest News about REGN
Recent news which mentions REGN
7 Value Stocks Worth Buying at These 52-Week Highs
March 22, 2023
From InvestorPlace
Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
March 22, 2023
From MarketWatch
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
March 09, 2023
From Motley Fool
How Is The Market Feeling About Regeneron Pharmaceuticals?
March 07, 2023
Tickers
REGN
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 5 Years
March 06, 2023
Tickers
REGN
From Benzinga
From Motley Fool
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
March 01, 2023
From Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
February 22, 2023
Tickers
REGN
From Benzinga
2 Top Healthcare Stocks Defying the Bear Market
February 14, 2023
From Motley Fool
From InvestorPlace
Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD
February 13, 2023
From Benzinga
2 Biotech Stocks That Could Help Set You Up for Life
February 11, 2023
From Motley Fool
From Benzinga
The 7 Best Biotech Stocks to Buy for February 2023
February 07, 2023
From InvestorPlace
Regeneron Pharmaceuticals Q4 Earnings: Revenue Falls As COVID-19-Related Sales Dwindle
February 03, 2023
Tickers
REGN
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
The 7 Most Undervalued Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
February 01, 2023
From InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
February 01, 2023
Tickers
REGN
From Benzinga
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
From Benzinga
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
January 30, 2023
From Benzinga
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
January 30, 2023
Tickers
REGN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.